Adalimumab 80mg weekly dose escalation for hidradenitis suppurativa: A multi-centre retrospective cohort study incorporating therapeutic drug monitoring
Wainman, Hannah E Chua, Ser Ling O'Kane, Donal Mehrtens, Sarah Ingram, John R
Wainman, Hannah E
Chua, Ser Ling
O'Kane, Donal
Mehrtens, Sarah
Ingram, John R
Abstract
No abstract available.
MIDER Authors
Date
2026-01-28
Type
Journal Article
Subject
Collections
Citation
Wainman HE, Chua SL, O'Kane D, Mehrtens S, Ingram JR. Adalimumab 80mg weekly dose escalation for hidradenitis suppurativa: A multi-centre retrospective cohort study incorporating therapeutic drug monitoring. Clin Exp Dermatol. 2026 Jan 28:llag044. doi: 10.1093/ced/llag044. Epub ahead of print.
Journal / Source Title
Clinical and experimental dermatology
DOI
10.1093/ced/llag044
PMID
41593033
Publisher
Oxford University Press